Methodology

All entries for: Excellamol Inc.

May 18, 2026

Excellamol Inc.

Orphan Drug Designation

treatment of malignant glioma

Disease Area: Rare Diseases
Source
May 17, 2026

Excellamol Inc.

Orphan Drug Designation

treatment of malignant glioma

Disease Area: Rare Diseases
Source
Scroll to Top